Selective beta 3 adrenergic agonist
The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compound...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DROSTE CHRISTINE ANN RITO CHRISTOPHER JOHN BELL MICHAEL GREGORY JESUDASON CYNTHIA DARSHINI SHUKER ANTHONY JOHN WINTER MARK ALAN |
| description | The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formulas I and II: |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US5977154A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US5977154A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US5977154A3</originalsourceid><addsrcrecordid>eNrjZFAOTs1JTS7JLEtVSEotSVQwVkhMKUrNSy1Kz0xWSEzPz8ssLuFhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJQA0l8aHBppbm5oamJo7GhFUAACwSJXw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Selective beta 3 adrenergic agonist</title><source>esp@cenet</source><creator>DROSTE; CHRISTINE ANN ; RITO; CHRISTOPHER JOHN ; BELL; MICHAEL GREGORY ; JESUDASON; CYNTHIA DARSHINI ; SHUKER; ANTHONY JOHN ; WINTER; MARK ALAN</creator><creatorcontrib>DROSTE; CHRISTINE ANN ; RITO; CHRISTOPHER JOHN ; BELL; MICHAEL GREGORY ; JESUDASON; CYNTHIA DARSHINI ; SHUKER; ANTHONY JOHN ; WINTER; MARK ALAN</creatorcontrib><description>The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formulas I and II:</description><edition>6</edition><language>eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991102&DB=EPODOC&CC=US&NR=5977154A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991102&DB=EPODOC&CC=US&NR=5977154A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DROSTE; CHRISTINE ANN</creatorcontrib><creatorcontrib>RITO; CHRISTOPHER JOHN</creatorcontrib><creatorcontrib>BELL; MICHAEL GREGORY</creatorcontrib><creatorcontrib>JESUDASON; CYNTHIA DARSHINI</creatorcontrib><creatorcontrib>SHUKER; ANTHONY JOHN</creatorcontrib><creatorcontrib>WINTER; MARK ALAN</creatorcontrib><title>Selective beta 3 adrenergic agonist</title><description>The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formulas I and II:</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAOTs1JTS7JLEtVSEotSVQwVkhMKUrNSy1Kz0xWSEzPz8ssLuFhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJQA0l8aHBppbm5oamJo7GhFUAACwSJXw</recordid><startdate>19991102</startdate><enddate>19991102</enddate><creator>DROSTE; CHRISTINE ANN</creator><creator>RITO; CHRISTOPHER JOHN</creator><creator>BELL; MICHAEL GREGORY</creator><creator>JESUDASON; CYNTHIA DARSHINI</creator><creator>SHUKER; ANTHONY JOHN</creator><creator>WINTER; MARK ALAN</creator><scope>EVB</scope></search><sort><creationdate>19991102</creationdate><title>Selective beta 3 adrenergic agonist</title><author>DROSTE; CHRISTINE ANN ; RITO; CHRISTOPHER JOHN ; BELL; MICHAEL GREGORY ; JESUDASON; CYNTHIA DARSHINI ; SHUKER; ANTHONY JOHN ; WINTER; MARK ALAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US5977154A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DROSTE; CHRISTINE ANN</creatorcontrib><creatorcontrib>RITO; CHRISTOPHER JOHN</creatorcontrib><creatorcontrib>BELL; MICHAEL GREGORY</creatorcontrib><creatorcontrib>JESUDASON; CYNTHIA DARSHINI</creatorcontrib><creatorcontrib>SHUKER; ANTHONY JOHN</creatorcontrib><creatorcontrib>WINTER; MARK ALAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DROSTE; CHRISTINE ANN</au><au>RITO; CHRISTOPHER JOHN</au><au>BELL; MICHAEL GREGORY</au><au>JESUDASON; CYNTHIA DARSHINI</au><au>SHUKER; ANTHONY JOHN</au><au>WINTER; MARK ALAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Selective beta 3 adrenergic agonist</title><date>1999-11-02</date><risdate>1999</risdate><abstract>The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formulas I and II:</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US5977154A |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Selective beta 3 adrenergic agonist |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T01%3A26%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DROSTE;%20CHRISTINE%20ANN&rft.date=1999-11-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS5977154A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |